Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents

European Journal of Medicinal Chemistry

Volumn 102, Issue , 2015, Pages 487-529

  Shaquiquzzaman, Mohammad ^a   Verma, Garima ^a   Marella, Akranth ^a   Akhter, Mymoona ^a   Akhtar, Wasim ^a   Khan, Mohemmed Faraz ^a   Tasneem, Sharba ^a   Alam, Mohammad Mumtaz ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Heterocyclic; Pharmacological activity; Piperazine

Indexed keywords

PIPERAZINE DERIVATIVE; ANALGESIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PIPERAZINE;

ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIDEPRESSANT ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOBESITY ACTIVITY; ANTIPSYCHOTIC ACTIVITY; ANTITUBERCULAR ACTIVITY; ANTIVIRAL ACTIVITY; CARDIOPROTECTIVE ACTIVITY; DRUG ACTIVITY; HEART PROTECTION; HUMAN; NONHUMAN; REVIEW; TRANQUILIZING ACTIVITY; ANIMAL; CHEMISTRY; SYNTHESIS;

ANALGESICS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFUNGAL AGENTS; HUMANS; PIPERAZINES;

EID: 85047695176     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2015.07.026     Document Type: Short Survey

References (314)

1. R. Dua S. Shrivastava S.K. Sonwane S.K. Shrivastava Pharmacological significance of synthetic heterocycles scaffold Adv. Biol. Res. 5 2011 120 144
2. M. Rudrapal B. De Chemistry and biological importance of heterocyclic Schiff's bases Int. Res. J. Pur. Appl. Chem. 3 2013 232 249
3. A.C. Tripathi S.J. Gupta G.N. Fatima P.K. Sonar A. Verma S.K. Saraf 4-Thiazolidinones: the advances continue. Eur. J. Med. Chem. 72 2014 52 77
4. N.K. Kaushik N. Kaushik P. Attri N. Kumar C.H. Kim A.K. Verma E.H. Choi Biomedical importance of indoles Molecules 18 2013 6620 6662
5. K.C. Majumdar Raj Kumar Nandi Sintu Ganai Synthesis of phosphorus containing medium ring heterocycles by sequential Claisen rearrangement and ring closing metathesis Tetrahedron Lett. 55 2014 1247 1250
6. V. Rachakonda M. Alla S.S. Kotipalli R. Ummani Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents Eur. J. Med. Chem. 70 2013 536 547
7. C. Premakumari A. Muralikrishna A. Padmaja V. Padmavathi S.J. Park T.J. Kim G.D. Reddy Synthesis, antimicrobial and anticancer activities of amido sulfonamido methane linked bis heterocycles Arab. J. Chem. 7 2014 385 395
8. X.Y. Guo G. Liu Scaffold-hopping strategy towards calanolides with nitrogen-containing heterocycles Chin. Chem. Lett. 24 2013 295 298
9. I. Khan A. Ibrar N. Abbas A. Saeed Recent advances in the structural library of functionalized quinazoline and quinazlinone scaffolds: synthetic approaches and multifarious applications Eur. J. Med. Chem. 76 2014 193 244
10. Chapter 5; piperazines Pharm. Lib. 25 1997 148 170
11. M. Jida M. Soueidan N. Willand F.A. Niedercorn L. Pelinski G. Laconde R.D. Poulain B. Deprez A facile and rapid synthesis of N-benzyl-2-substituted piperazines Tetrahedron Lett. 52 2011 1705 1708
12. A. Ahmed K.I. Molvi S. Nazim I. Baig T. Memon M. Rahil The importance of six membered saturated nitrogen containing ring in psychological disorders J. Chem. Pharm. Res. 4 2012 872 880
13. M.K. Akkoc M.Y. Yuksel I. Durmaz R.C. Atalay Design, synthesis, and biological evaluation of indole-based 1,4-disubstituted piperazines as cytotoxic agents Turk. J. Chem. 36 2012 515 525
14. V.K. Jain B. Jain U.K. Sharma D. Saha Synthesis, characterization and antimicrobial screening of some 4-substituted-1-(4-substituted phenyl) piperazine derivatives Int. J. Curr. Pharm. Res. 3 2011 66 70
15. C.P. Meher A.M. Rao M. Omar Piperazine-pyrazine and their multiple biological activities Asian J. Pharm. Sci. Res. 3 2013 43 60
16. L.L. Gan B. Fang C.H. Zhou Synthesis of azole-containing piperazine derivatives and evaluation of their antibacterial, antifungal and cytotoxic activities Bull. Korean Chem. 31 2010 3864 3892
17. N.K. Joshi D.S. Kundariya J.M. Parmar Synthesis, characterization and antimicrobial evaluation of some novel 1,3,4-oxadiazoles containing piperazine moiety Int. J. ChemTech Res. 24 2012 1503 1508
18. E. Ibezim P.R. Duchowicz E.V. Ortiz E.A. Castro QSAR on aryl-piperazine derivatives with activity on malaria Chemom. Intell. Lab. 110 2012 81 88
19. D. Mukherjee A. Mukhopadhayay K. Shridhara Bhat A.M. Shridhara K.S. Rao Synthesis, characterization and anticonvulsant activity of substituted 4-chloro-2-(4-piperazin-1-yl) quinazolines Int. J. Pharm. Pharm. Sci. 6 2014 567 571
20. S.D. Cho S.Y. Song K.H. Kim B.X. Zhao C. Ahn W.H. Joo Y.J. Yoon J.R. Falck D.S. Shin One-pot synthesis of symmetrical 1,4-disubstituted piperazine-2,5-diones Bull. Korean Chem. Soc. 25 2004 415 416
21. S. Ashour N. Kattan Simultaneous determination of nortriptyline hydrochloride and fluphenazine hydrochloride in microgram quantities from low dosage forms by liquid chromatography-UV detection J. Pharm. Anal. 2 2012 437 442
22. L. Guo Y. Zhang Q. Li Spectrophotometric determination of perphenazine with the detection system of potassium ferricyanide-Fe(III) in pharmaceutical and serum samples Spectrochim. Acta A 74 2009 307 311
23. J.M. Dhabab S.A.H.A. Ameri A.H. Taufeeq Separation and determination of trifluoperazine and prochlorperazine in pharmaceutical preparations by HPLC J. Assoc. Arab Univ. Basic Appl. Sci. 13 2013 14 18
24. M. Yan Y.G. Zhu H.D. Li B.M. Chen N. Ma Y.Q. Lei Y.P. Liu Quantification of prochlorperazine maleate in human plasma by liquid chromatography-mass spectrometry: application to bioequivalence study J. Chromatogr. B 877 2009 3243 3247
25. C. Davis Thiothixene; xPharm: the Comprehensive Pharmacol. Ref. 2007 1 6
26. S. Walter S. Bauer I. Roots J. Brockmoller Quantification of the antipsychotics flupentixol and haloperidol in human serum by high-performance liquid chromatography with ultraviolet detection J. Chromatogr. Biomed. 720 1998 231 237
27. Z. Sentruk S.A. Ozkan Y. Ozkan H.Y.A. Enein Voltammetric investigation of oxidation of zuclopenthixol and application to its determination in dosage forms and in drug dissolution studies J. Pharm. Biomed. Anal. 22 2000 315 323
28. J. Su H. Tang B.A. Mckittrick D.A. Burnett H. Zhang A.S. Torhan A. Fawzi J. Lachowicz Modification of clozapine structure by parallel synthesis Bioorg. Med. Chem. Lett. 16 2006 4548 4553
29. F. Vincent M.T. Nguyen D.E. Emerling M.G. Kelly M.A.J. Duncton Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors Bioorg. Med. Chem. Lett. 19 2009 6793 6796
30. P.S. Rao U.K. Ray S.G. Hiriyanna S.V. Rao H.K. Sharma V.K. Handa K. Mukkanti Identification of oxidative degradation impurities of olanzapine drug substances as well as drug product J. Pharm. Biomed. Anal. 56 2011 413 418
31. 3 receptors Eur. J. Med. Chem. 60 2013 42 60
32. O. Ichikawa K. Okazaki H. Nakahira M. Maruyama R. Nagata K. Tokuda T. Horisawa K. Yamazaki Structural insight into receptor-selectivity for lurasidone Neurochem. Int. 61 2012 1133 1143
33. K.Y. Li Y.G. Zhou H.Y. Ren F. Wang B.K. Zhang H.D. Li Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of atypical antipsychotics and some metabolites in in vitro samples J. Chromatogr. B 850 2007 581 585
34. L. Mercolini M. Protti G. Fulgenzi R. Mandrioli N. Ghedini A. Conca M.A. Raggi A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma J. Pharm. Biomed. Anal. 88 2014 467 471
35. G.E. Gaillard Clinical evaluation of a new antihistamine, buclizine hydrochloride (Vibazine) J. Allergy 26 1955 373 376
36. N.H. Al-Shaalan Extractive spectrophotometric assay of cyclizine in a pharmaceutical formulation and biological fluids Saudi Pharm. J. 20 2012 255 262
37. J.C. Lin Y.S. Ho J.J. Lee C. Liu T.L. Yang C.H. Wu Induction of apoptosis and cell-cycle arrest in human colon cancer cells by meclizine Food Chem. Toxicol. 45 2007 935 944
38. M.M. Abdelrahman Simultaneous determination of cinnarizine and domperidone by area under curve and dual wavelength spectrophotometric methods Spectrochim. Acta A 113 2013 291 296
39. T.R. Sherrod Antispasmodic properties of hydroxyzine (Atarax) Toxicol. Appl. Pharmacol. 1 1959 162 167
40. M. Sanjuan V. Rovei J. Dow M.S. Benedetti Mass spectrometric studies of the metabolites of niaprazine Int. J. Mass Spectrom. Ion Phys. 48 1983 93 96
41. H.A.J.A. Lawati E.A. Gharibi S.M.Z.A. Kindy F.E.O. Suliman A.M.A. Lawati High throughput method for the analysis of cetrizine hydrochloride in pharmaceutical preparations and biological fluids using a tris(2,2′-bipyridyl)ruthenium(II)-peroxydisulphate chemiluminescence system in a two-chip device Talanta 85 2011 906 912
42. T. Kalai M. Khan M. Balog V.K. Kutala P. Kuppusamy K. Hideg Structure-activity studies on the protection of trimetazidine derivatives modified with nitroxides and their precursors from myocardial ischemia-reperfusion injury Bioorg. Med. Chem. 14 2006 5510 5516
43. V. Malati A.R. Reddy K. Mukkanti M.V. Suryanarayana A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product Talanta 97 2012 563 573
44. 1A receptors partial agonists II Farmaco 57 2003 917 923
45. A. Fulton T. Norman G.D. Burrows Ligand binding and platelet uptake studies of loxapine, amoxapine and their 8-hydroxylated derivatives J. Affect. Disord. 4 1982 113 119
46. D. Dauzonne J.M. Gillardin F. Lepage R. Pointet S. Risse G. Lamotte P. Demerseman Synthesis and some CNS activities of new benzofuranylacryloylpiperazines Eur. J. Med. Chem. 30 1995 53 59
47. 2 receptor activity Bioorg. Med. Chem. 13 2005 1195 1200
48. G. Bianchi S. Caccia Simultaneous determination of buspirone, gepirone ipsapirone and their common metabolite 1-(2-pyrimidinyl)piperazine in rat plasma and brain by high-performance liquid chromatography J. Chromatogr. 431 1988 477 480
49. M.D. Ennis N.B. Ghazal The synthesis of (+)-and(-)-flesinoxan: application of enzymatic resolution methodology Tetrahedron Lett. 33 1992 6287 6290
50. D.S. Shin M.J. Park H.A. Lee J.Y. Lee H.C. Chung D.S. Yoo C.H. Chae S.J. Park K.S. Kim M.A. Bae A novel assessment of nefazodone-induced hERG inhibition by electrophysiological and stereochemical method Toxicol. Appl. Pharmacol. 274 2014 361 371
51. W.S.X. Yang W. Yu Y. Jin X. Luan X. Wang H. Xu A validated LC-MS/MS method for the rapid quantification of vilazodone in rat plasma: application to a pharmacokinetic study J. Pharm. Biomed. Anal. 98 2014 228 234
52. 4 receptor ligands Bioorg. Med. Chem. Lett. 11 2001 1141 1144
53. D. Yonar M.M. Sunnetcioglu Spectroscopic and calorimetric studies on trazodone hydrochloride-phosphatidylcholine liposome interactions in the presence and absence of cholesterol Biochim. Biophys. Acta Biomembr. 1838 2014 2369 2379
54. J. Yoo K.M. Thai D.K. Kim J.Y. Lee H.J. Park 3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors Bioorg. Med. Chem. Lett. 17 2007 4271 4274
55. J.C. Reepmeyer J.T. Woodruff Use of liquid chromatography-mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a g€œFOR VERIFICATION naturalg€ FOR VERIFICATION herbal dietary supplement J. Chromatogr. A 1125 2006 67 75
56. P.R. Guinebault M. Broquaire M. Sanjuan V. Rovei R.A. Braithwaite Determination of antrafenine and its main acid metabolite, 2-{[7-(trifluoromethyl)-4-quinolinyl]amino}-benzoic acid, in biological fluids using high-performance liquid chromatography with large volume automatic injection and gas-liquid chromatography with derivative formation J. Chromatogr. Biomed. Sci. 223 1981 103 110
57. R.F. Staack H.H. Maurer Studies on the metabolism and toxicological analysis of the nootropic drug fipexide in rat urine using gas chromatography-mass spectrometry J. Chromatogr. B 804 2004 337 343
58. 3 receptor Bioorg. Med. Chem. 13 2005 3455 3460
59. P.W. Manley F. Blasco J. Mestan R. Aichholz The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588 Bioorg. Med. Chem. 21 2013 3231 3239
60. M. Since T. Freret G. Nee T. Terme P. Vanelle M. Boulouard New orally effective 3-(2-nitro)phenylpropanamide analgesic derivatives: synthesis and antinociceptive evaluation Eur. J. Med. Chem. 69 2013 728 734
61. G. Verma A. Marella M. Shaquiquzzaman M.M. Alam Immunoinflammatory responses in gastrointestinal tract injury and recovery Acta Biochim. Pol. 60 2013 143 149
62. S.V. Bhandari K.G. Bothara M.K. Raut A.A. Patil A.P. Sarkate V.J. Mokale Bioorg. Med. Chem. 16 2008 1822 1831
63. B. Tozkoparan E. Kupeli E. Yesilada M. Ertan Preparation of 5-aryl-3-alkylthio-1,2,4-triazoles and corresponding sulfones with anti-inflammatory-analgesic activity Bioorg. Med. Chem. 15 2007 1808 1814
64. A. Husain A. Ahmad M.M. Alam M. Ajmal P. Ahuja Fenbufen based 3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]-1-(biphenyl-4-yl)propan-1-ones as safer anti-inflammatory and analgesic agents Eur. J. Med. Chem. 44 2009 3798 3804
65. B. Tozkoparan G. Aktay E. Yesilada Synthesis of some 1,2,4-triazolo[3,2-b]-1,3-thiazine-7-ones with potential analgesic and anti-inflammatory activities II Farmaco 57 2002 145 152
66. A. Boido C.C. Boido F. Sparatore Synthesis and pharmacological evaluation of aryl/heteroaryl piperazinyl alkyl benzotriazoles as ligands for some serotonin and dopamine receptor subtypes II Farmaco 56 2001 263 275
67. H. Sladowska B. Filipek D. Szkatula A. Sabiniarz M. Kardasz J. Potoczek M. Sieklucka-Dziuba G. Rajtar Z. Kelinork T. Lis Investigations on the synthesis and pharmacological properties of alkoxy-2-[2-hydroxy-3-(4-aryl-1-piperazinyl)propyl]-6-methyl-1H-pyrrolo[3,4-c]pyridine-1,3-(2H)-diones II Farmaco 57 2002 897 908
68. N. Sultana A. Naz B. Khan M.S. Arayne M.A. Mesaik Synthesis, characterization, antibacterial, antifungal, and immunomodulating activities of gatifloxacin derivatives Med. Chem. Res. 19 2010 1210 1221
69. W. Malinka A. Redzicka M. Jastrzebska-Wiesek B. Filipek M. Dybala Z. Karczmarzyk Z. Urbanczyk-Lipkowska P. Kalicki Derivatives of pyrrolo[3,4- d ]pyridazinone, a new class of analgesic agents Eur. J. Med. Chem. 46 2011 4992 4999
70. M.M. Saeed N.A. Khalil E.M. Ahmed K.I. Eissa Synthesis and anti-inflammatory activity of novel pyridazine and pyridazinone derivatives as non-ulcerogenic agents Arch. Pharm. Res. 35 2012 2077 2092
71. G.D. Hatnapure A.P. Keche A.H. Rodge S.S. Birajdar R.H. Tale V.M. Kamble Synthesis and biological evaluation of novel piperazine derivatives of flavone as potent anti-inflammatory and antimicrobial agent Bioorg. Med. Chem. Lett. 22 2012 6385 6390
72. M. Kono T. Matsumoto T. Kawamura A. Nishimura Y. Kiyota H. Oki J. Miyazaki S. Igaki C.A. Behnke M. Shimojo M. Kori Synthesis, SAR study, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase (FAAH) inhibitors Bioorg. Med. Chem. 21 2013 28 41
73. N. Sultana M.S. Arayne A. Naz M.A. Mesaik Identification of anti-inflammatory and other biological activities of 3-carboxamide, 3-carbohydrazide and ester derivatives of gatifloxacin Chem. Cent. J. 7 2013 1 11
74. M. Kono T. Matsumoto T. Imaeda T. Kawamura S. Fujimoto Y. Kosugi T. Odani Y. Shimizu H. Matsui M. Shimojo M. Kori Design, synthesis and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors Bioorg. Med. Chem. 22 2014 1468 1478
75. V. Agarwal A. Agarwal Acute and chronic bacterial infections in rheumatology practice Indian J. Rheumatol. 6 2011 69 74
76. J. Nuutila P. Jalava-Karvinen U. Hohenthal P. Kotilainen T.T. Pelliniemi J. Nikoskelainen E.M. Lilius Bacterial infection (BI)-index: an improved and simplified rapid flow cytometric bacterial infection marker Diagn. Microbiol. Infect. Dis. 78 2014 116 126
77. H.R. Kim S.S. Hwang E.C. Kim S.M. Lee S.C. Yang C.G. Yoo Y.W. Kim S.K. Han Y.S. Shim J.J. Yim Risk factors for multidrug-resistant bacterial infections among patients with tuberculosis J. Hosp. Infect. 77 2011 134 137
78. L. Beibei C. Yun C. Mengli B. Nan Y. Xuhong W. Rui Linezolid versus vancomycin for the treatment of Gram-positive bacterial infections: meta-analysis of randomized controlled trials Int. J. Antimicrob. Agents 35 2010 3 12
79. Y.L. Chen K.C. Fang J.Y. Sheu S.L. Hsu C.C. Tzeng Synthesis and antibacterial evaluation of certain quinolone derivatives J. Med. Chem. 44 2001 2374 2377
80. A. Foroumadi F. Soltani M.H. Moshafi R. Ashraf-Askari Synthesis and in vitro antibacterial activity of some N-(5-aryl-1,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives II Farmaco 58 2003 1023 1028
81. R.J. Kerns M.J. Rybak G.W. Kaatz F. Vaka R. Cha R.G. Grucz V.U. Diwadkar Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus Bioorg. Med. Chem. Lett. 13 2003 2109 2112
82. C.H. Oh S.C. Lee J.H. Cho Synthesis and biological activity of 1β-methyl-2-[5-(2-N-substituted aminoethylcarbamoyl)pyrrolidin-3-ylthio]carbapenem derivatives Eur. J. Med. Chem. 38 2003 841 850
83. A. Foroumadi S. Mansouri Z. Kiani A. Rahmani Synthesis and in vitro antibacterial evaluation of N-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-yl] piperazinyl quinolones 38 2003 851 854
84. O.A. Phillips E.E. Udo A.A.M. Ali S.M. Samuel Synthesis and antibacterial activity of new N-linked 5-triazolylmethyl oxazolidinones Bioorg. Med. Chem. 13 2005 4113 4123
85. A. Foroumadi S. Emami A. Hassanzadeh M. Rajaee K. Sokhanvar M.H. Moshafi A. Shafiee Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives Bioorg. Med. Chem. Lett. 15 2005 4488 4492
86. A. Foroumadi S. Emami M. Mehni M.H. Moshafi A. Shafiee Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones Bioorg. Med. Chem. Lett. 15 2005 4536 4539
87. P. Chaudhary R. Kumar A.K. Verma D. Singh V. Yadav A.K. Chhillar G.L. Sharma R. Chandra Synthesis and antimicrobial activity of N-alkyl and N-aryl piperazine derivatives Bioorg. Med. Chem. 14 2006 1819 1826
88. A. Foroumadi S. Ghodsi S. Emami S. Najjari N. Samadi M.A. Faramarzi L. Beikmohammadi F.H. Shirazi A. Shafiee Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl) piperazine moiety Bioorg. Med. Chem. Lett. 16 2006 3499 3503
89. J.N.N.S. Chandra C.T. Sadashiva C.V. Kavitha K.S. Rangappa Synthesis and in vitro antimicrobial studies of medicinally important novel N-alkyl and N-sulfonyl derivatives of 1-[bis(4-fluorophenyl)-methyl]piperazine Bioorg. Med. Chem. 14 2006 6621 6627
90. A. Foroumadi M. Oboudiat S. Emami A. Karimollah L. Saghaee M.H. Moshafi A. Shafiee Synthesis and antibacterial activity of N-[2-[5-(methylthio)thiophen-2-yl]-2-oxoethyl] and N-[2-[5[(methylthio)thiophen-2-yl]-2-(oxyimino)ethyl]piperazinylquinolone derivatives Bioorg. Med. Chem. 14 2006 3421 3427
91. S. Talath A.K. Gadad Synthesis, antibacterial and antitubercular activities of some 7-[4-(5-amino-[1,3,4]thiadiazole-2-sulfonyl)-piperazin-1-yl]fluoroquinolonic derivatives Eur. J. Med. Chem. 41 2006 918 924
92. M. Takhi C. Murugan M. Munikumar K.M. Bhaskarreddy G. Singh K. Sreenivas M. Sitaramkumar N. Selvakumar J. Das S. Trehan J. Iqbal Synthesis and antibacterial activity of some novel oxazolidinones bearing N-hydroxyacetamide substituent Bioorg. Med. Chem. Lett. 16 2006 2391 2395
93. B.B. Lohray V.B. Lohray B.K. Srivastava S. Gupta M. Solanki P. Pandya P. Kapandis Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials Bioorg. Med. Chem. Lett. 16 2006 1557 1561
94. A. Foroumadi S. Mansouri S. Emami J. Mirzaei M. Sorkhi N. Saeid-Adeli A. Shafiee Synthesis and antibacterial activity of nitroaryl thiadiazole-levofloxacin hybrids Arch. Pharm. Chem. Life Sci. 339 2006 621 624
95. J. Liu B. He A. Yu W. Zhou Synthesis and in vitro evaluation of substituted phenyl-piperazinyl-phenyl oxazolidinones against Gram-positive bacteria Chem. Biol. Drug Des. 69 2007 265 268
96. A. Foroumadi N. Mohammadhosseini S. Emami B. Letafat M.A. Faramarzi N. Samadi A. Shafiee Synthesis and antibacterial activity of new 7-piperazinyl-quinolones containing a functionalized 2-(furan-3-yl)ethyl moiety Arch. Pharm. Chem. Life Sci. 340 2007 47 52
97. Y.X. Yang H.Y. Guo Synthesis of 6,8-dichloroquinolones utilizing new method and evaluation of their antibacterial activities Chin. Chem. Lett. 18 2007 1479 1482
98. A. Foroumadi S. Emami S. Mansouri A. Javidina N. Saeid-Adeli F.H. Shirazi A. Shafiee Synthesis and antibacterial activity of levofloxacin derivatives with certain bulky residues on piperazine ring Eur. J. Med. Chem. 42 2007 985 992
99. A. Foroumadi L. Firoozpour S. Emami S. Mansouri A.H. Ebahimabadi A. Asadipour M. Amini N. Saeid-Adeli A. Shafiee Synthesis and antibacterial activity of N-[5-(chlorobenzylthio)-1,3,4-thiadiazol-2-yl] piperazinyl quinolone derivatives Arch. Pharm. Res. 30 2007 138 145
100. Y. Hirokawa H. Kinoshita T. Tanaka K. Nakata N. Kitadai K. Fujimoto S. Kashimoto T. Kojima S. Kato Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against Gram-positive pathogens J. Med. Chem. 51 2008 1991 1994
101. S. Emami A. Foroumadi N. Samadi M.A. Faramarzi S. Rajabalian Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-Dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones Arch. Pharm. Chem. Life Sci. 342 2009 405 411
102. S. Jazayeri M.H. Moshafi L. Firoozpour S. Emami S. Rajabalian M. Haddad F. Pahlavanzadeh M. Esnaashari A. Shafiee A. Foroumadi Synthesis and antibacterial activity of nitroaryl thiadiazole-gatifloxacin hybrids Eur. J. Med. Chem. 44 2009 1205 1209
103. Y. Hirokawa H. Kinoshita T. Tanaka T. Nakamura K. Fujimoto S. Kashimoto T. Kojima S. Kato Pleuromutilin derivatives having a purine ring. Part 3: synthesis and antibacterial activity of novel compounds possessing a piperazine ring spacer Bioorg. Med. Chem. Lett. 19 2009 175 179
104. G.E.D.A.A. Abuo-Rahma H.A. Sarhan G.F.M. Gad Design, synthesis, antibacterial activity and physicochemical parameters of novel N-4-piperazinyl derivatives of norfloxacin Bioorg. Med. Chem. 17 2009 3879 3886
105. S. Kapic H.C. Paljetak I.P. Jakopovic A. Fajdetic M. Ilijas V. Stimac K. Brajsa D.J. Holmes J. Berge S. Alihodzic Synthesis of macrolones with central piperazine ring in the linker and its influence on antibacterial activity Bioorg. Med. Chem. Lett. 19 2011 7281 7298
106. K.T. Chue M.S. Chang L.N. Ten Synthesis and antibacterial activity of betulonic acid amides with piperazine derivatives Chem. Nat. Compd. 47 2011 759 763
107. S. Wang X.D. Jia M.L. Liu Y. Lu H.Y. Guo Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety Bioorg. Med. Chem. Lett. 22 2012 5971 5975
108. N. Mohammadhosseini Z. Alipanahi E. Alipour S. Emami M.A. Faramarzi N. Samadi N. Khoshnevis A. Shafiee A. Foroumadi Synthesis and antibacterial activity of novel levofloxacin derivatives containing a substituted thienylethyl moiety DARU J. Pharm. Sci. 20 2012 2 6
109. R.V. Patel P. Kumari D.P. Rajani K.H. Chikhalia Discovery of 2-(4-cyano-3-trifluoromethylphenyl amino)-4-(4-quinazolinyloxy)-6-piperazinyl(piperidinyl)-s-triazines as potential antibacterial agents Med. Chem. Res. 21 2012 4177 4192
110. D. Patel P. Kumari N. Patel Synthesis of 3-{4-[4-dimethylamino-6-(4-methyl-2-oxo-2H-chromen-7-yloxy)-[1,3,5]triazin-2-ylamino]-phenyl}-2-phenyl-5-(4-pyridin-2yl-piperazin-1-ylmethyl)-thiazolidin-4-one and their biological evaluation Med. Chem. Res. 21 2012 2926 2944
111. S. Emami E. Ghafouri M.A. Faramarzi N. Samadi H. Irannejad A. Foroumadi Mannich bases of 7-piperaznylquinolones and kojic acid derivatives: synthesis, in vitro antibacterial study and in silico study Eur. J. Med. Chem. 68 2013 185 191
112. M.H. Malani B.Z. Dholakiya Synthesis, characterization and in vitro screening on bacterial, fungal and malarial strain of piperazinyl cyano biphenyl based compounds Bioorg. Chem. 51 2013 16 23
113. S.G. Shingade S.B. Bari Synthesis and antimicrobial screening of thiazolidinone and 2-azetidinone derivatives of piperazine Med. Chem. Res. 22 2013 699 706
114. A.A. El-Emam A.M.S. Al-Tamimi M.A. Al-Omar K.A. Alrashood E.E. Habib Synthesis and antimicrobial activity of novel 5-(1-adamantyl)-2-aminoethyl-4-substituted-1,2,4-triazoline-3-thiones Eur. J. Med. Chem. 68 2013 96 102
115. S.F. Wang Y. Yin F. Qiao X. Wu S. Sha L. Zhang H.L. Zhu Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents Bioorg. Med. Chem. 22 2014 2409 2415
116. N. Suresh H.N. Nagesh J. Renuka V. Rajput R. Sharma I.A. Khan C.S.K.V. Gowri Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)acetyl)piperazin-1-yl)quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents Eur. J. Med. Chem. 71 2013 324 332
117. A. Mohammadi Novel triazene dyes based on N-phenylpiperazine: synthesis, antibacterial activity and solvatochromic properties J. Mol. Lipids 193 2014 69 73
118. B. Marquez V. Pourcelle C.M. Vallet M.P.M. Ledercq P.M. Tulkens J.M. Bruynaert F.V. Bambeke Pharmacological characterization of 7-(4-(piperazin-1-yl)) ciprofloxacin derivatives: antibacterial activity, cellular accumulation, susceptibility to efflux transporters, and intracellular activity Pharm. Res. 31 2014 1290 1301
119. R.V. Patel S.W. Park Catalytic N-formylation for synthesis of 6-substituted-2-benzothiazolylimino-5-pperazinyl-4-thiazolidinone antimicrobial agents Res. Chem. Intermed. 41 2015 5599 5609
120. R.V. Patel S.W. Park Synthesis of highly potent piperazine-linked benzothiazolyl-4-thiazolidinones via catalytic N-formylation: antibacterial drug design Med. Chem. Res. 23 2014 4099 4107
121. A.E. Yuzhalin A.G. Kutikhin Chapter: 1. Introduction: basic concepts Interleukins Cancer Biol. 2015 1 16
122. Y. Yarden C. Caldes Basic cancer research is essential for the success of personalized medicine Eur. J. Cancer 49 2013 2619 2620
123. A. Ranise A. Spallarossa O. Bruno S. Schenone P. Fossa G. Menozzi F. Bondavalli L. Mosti A. Capuano F. Mazzeo G. Falcone W. Filippelli Synthesis of N-substituted-N-acylthioureas of 4-substituted piperazines endowed with local anaesthetic, antihyperlipidemic, antiproliferative activities and antiarrythmic, analgesic, antiaggregating actions II Farmaco 58 2003 765 780
124. X. Hou Z. Ge T. Wang W. Guo J. Cui T. Cheng C. Lai R. Li Dithiocarbamic acid esters as anticancer agent. Part 1: 4-substituted-piperazine-1-carbodithioic acid 3-cyano-3,3-diphenyl-propyl esters Bioorg. Med. Chem. Lett. 16 2006 4214 4219
125. W. Hu W. Zhou C. Xia X. Wen Synthesis and anticancer activity of thiosemicarbazones Bioorg. Med. Chem. Lett. 16 2006 2213 2218
126. A. Kamal P.S.M.M. Reddy D.R. Reddy E. Laxman DNA binding potential and cytotoxicity of newly designed pyrrolobenzodiazepine dimers linked through a piperazine side-armed alkane spacer Bioorg. Med. Chem. 14 2006 385 394
127. R. Filosa A. Peduto P. Caprariis C. Saturnino M. Festa A. Petrella A. Pau G.A. Pinna P. Colla B. Busonera R. Loddo Synthesis and antiproliferative properties of N3/8-disubstituted 3,8 diazabicyclo[3.2.1]octane analogues of 3,8-bis[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl-piperazine Eur. J. Med. Chem. 42 2007 293 306
128. A. Pardakhty A. Foroumadi M. Hashemi S. Rajabalian M.R. Heidari In vitro cytotoxicity and phototoxicity of N-piperazinyl quinolone derivatives with a 2-thienyl group Toxicol. In Vitro 21 2007 1031 1038
129. W. Huang M.Z. Liu Y. Li Y. Tan G.F. Yang Design, syntheses, and antitumor activity of novel chromone and aurone derivatives Bioorg. Med. Chem. 15 2007 5191 5197
130. C.S.A. Kumar S.N. Swamy N.R. Thimmegowda S.B.B. Prasad G.W. Yip K.S. Rangappa Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of MDA-MB-231 human breast cancer cell proliferation Med. Chem. Res. 16 2007 179 187
131. M. Shaharyar M.A. Ali M.M. Abdullah Synthesis and antiproliferative activity of 1-[(sub)]-6-fluro-3-[(sub)]-1,3,4-oxadiazol-2-yl-7-piperazino-1,4-dihydro-4-quinolinone derivatives Med. Chem. Res. 16 2007 292 299
132. L.E. Kihel M. Clement M.A. Bazin G. Descamps M. Khalid S. Rault New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines Bioorg. Med. Chem. 16 2008 8737 8744
133. A. Kamal R. Ramu V. Tekumalla G.B.R. Khanna M.S. Barkume A.S. Juvekar S.M. Zingde Remarkable DNA binding affinity and potential anticancer activity of pyrrolo[2,1-c][1,4]benzodiazepine-naphthalimide conjugates linked through piperazine side-armed alkane spacers Bioorg. Med. Chem. 16 2008 7218 7224
134. S. Zeng W. Liu F. Nie Q. Zhao J. Rong J. Wang L. Tao Q. Qi N. Lu Z. Li Q.L. Guo LYG-202, a new flavonoid with piperazine substitution, shows antitumor effects in vivo and in vitro Biochem. Biophys. Res. Commun. 385 2009 551 556
135. A. Foroumadi S. Emami S. Rajabalian M. Badinloo N. Mohammadhosseini A. Shafiee N-substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study Biomed. Pharmacother. 63 2009 216 220
136. C.S.A. Kumar S.B.B. Prasad K. Vinaya S. Chandrappa N.R. Thimmegowda Y.C.S. Kumar S. Swarup K.S. Rangappa Synthesis and in vitro antiproliferative activity of novel 1-benzhydrylpiperazine derivatives against human cancer cell lines Eur. J. Med. Chem. 44 2009 1223 1229
137. S. Kumar N. Shakya S. Gupta J. Sakar D.P. Sahu Synthesis and biological evaluation of novel 4-(hetero) aryl-2-piperazino quinazolines as anti-leishmanial and anti-proliferative agents Bioorg. Med. Chem. Lett. 19 2009 2542 2545
138. R.V. Patel P. Kumari D.P. Rajani K.H. Chikhalia Synthesis and studies of novel 2-(4-cyano-3-trifluoromethylphenyl amino)-4-(quinoline-4-yloxy)-6-(piperazinyl/piperidinyl)-s-triazines as potential antimicrobial, antimycobacterial and anticancer agents Eur. J. Med. Chem. 46 2011 4354 4365
139. L. Nagarapu H.K. Gaikwad R. Bantu S.R. Manikonda Chemoenzymatic synthesis with lipase catalyzed resolution and evaluation of antitumor activity of (R/S)-2-[2-hydroxy-3-(4-phenylpiperazin-1-yl)propyl]-1Hpyrrolo[3,4-b]quinolin-3(2H)-one Eur. J. Med. Chem. 46 2011 2152 2156
140. H.M. Shallal W.A. Russu Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives Eur. J. Med. Chem. 46 2011 2043 2057
141. M.S.R. Murty K.R. Ram R.V. Rao J.S. Yadav J.V. Rao V.T. Cheriyan R.J. Anto Synthesis and preliminary evaluation of 2-substituted-1,3-benzoxazole and 3-[(3-substituted)propyl]-1,3-benzoxazol-2(3H)-one derivatives as potent anticancer agents Med. Chem. Res. 20 2011 576 586
142. L. Mallesha K.N. Mohana B. Veeresh R. Alvala A. Mallika Synthesis and in vitro antiproliferative activity of 2-methyl-3-(2-piperazin-1-yl-ethyl)-pyrido[1,2-a]pyrimidin-4-one derivatives against human cancer cell lines Arch. Pharm. Res. 35 2012 51 57
143. S.L. Cao Y. Han C.Z. Yuan Y. Wang Z.K. Xiahou J. Liao R.T. Gao B.B. Mao B.L. Zhao Z.F. Li X. Xu Synthesis and antiproliferative activity of 4-substituted piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline Eur. J. Med. Chem. 64 2013 401 409
144. H.H. Lin W.Y. Wu S.L. Cao J. Liao L. Ma M. Gao Z.F. Li X. Xu Synthesis and antiproliferative evaluation of piperazine-1-carbothiohydrazide derivatives of indolin-2-one Bioorg. Med. Chem. Lett. 23 2013 3304 3307
145. Y.C. Duan Y.C. Ma E. Zhang X.J. Shi M.M. Wang X.W. Ye H.M. Liu Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents Eur. J. Med. Chem. 62 2013 11 19
146. U. Kulandaivelu B. Shireesha C. Mahesh J.V. Vidyasagar T.R. Rao K.N. Jayaveera P. Saiko G. Graser T. Szekeres V. Jayaprakash Synthesis antimicrobial and anticancer activity of N′-arylmethylidene-piperazine-1-carbothiohydrazide Med. Chem. Res. 22 2013 2802 2808
147. R.N. Sharma R. Ravani Synthesis and screening of 2-(2-(4-substituted piperazine-1-yl)-5-phenylthiazol-4-yl)-3-aryl quinazolinone derivatives as anticancer agents Med. Chem. Res. 22 2013 2788 2794
148. M.S.R. Murty B.R. Rao M.R. Katiki L.R. Nath R.J. Anto Synthesis of piperazinyl benzothiazole/benzoxazole derivatives coupled with 1,3,4-oxadiazole-2-thiol: novel hybrid heterocycles as anticancer agents Med. Chem. Res. 22 2013 4980 4991
149. N. Inceler A. Yilmaz S.N. Baytas Synthesis of ester and amide derivatives of 1-phenyl-3-(thiophen-3-yl)-1H-pyrazole-4 carboxylic acid and study of their anticancer activity Med. Chem. Res. 22 2013 3109 3118
150. L.H. Huang H.D. Xu Z.Y. Yang Y.F. Zheng H.M. Liu Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues Steroids 82 2014 1 6
151. K.S.S. Kumar A. Hanumappa M. Hegde K.H. Narasimhamurthy S.C. Raghavan K.S. Rangappa Synthesis and antiproliferative effect of novel 4-thiazolidinone-, pyridine- and piperazine-based conjugates on human leukemic cells Eur. J. Med. Chem. 81 2014 341 349
152. S. Liao X. Qin D. Li Z. Tu J. Li X. Zhou J. Wang B. Yang X. Lin J. Liu X. Yang Y. Liu Design and synthesis of novel soluble 2,5-diketopiperazine derivatives as potential anticancer agents Eur. J. Med. Chem. 83 2014 236 244
153. Y. Zhang Y.J. Huang H.M. Xiang P.Y. Wang D.Y. Hu W. Xue B.A. Song S. Yang Synthesis and anticancer activities of 4-(4-substituted piperazin)-5,6,7-trialkoxy quinazoline derivatives Eur. J. Med. Chem. 78 2014 23 34
154. H.N. Nagesh N. Suresh G.V.S.B. Prakash S. Gupta J.V. Rao K.V.G.C. Sekhar Synthesis and Biological Evaluation of Novel Phenanthridinyl Piperazine Triazoles via Click Chemistry as Antiproliferative Agents 2014
155. M.S.R. Murty K.R. Ram B.R. Rao R.V. Rao M.R. Katiki J.V. Rao R. Pamanji L.R. Velatooru Synthesis, characterization, and anticancer studies of S and N alkyl piperazine-substituted positional isomers of 1,2,4-triazole derivatives Med. Chem. Res. 23 2014 1661 1671
156. C. Fytas G. Zoidis A. Tsotinis G. Fytas M.A. Khan S. Akhtar K.M. Rahman D.E. Thurston Novel 1-(2-aryl-2-adamantyl)piperazine derivatives with antiproliferative activity Eur. J. Med. Chem. 93 2015 281 290
157. A. Kamal K. Sreekanth N. Shankaraiah M. Sathish S. Nekkanti V. Srinivasulu Dithiocarbamate/piperazine bridged pyrrolobenzodiazepines as DNA-minor groove binders: synthesis, DNA-binding affinity and cytotoxic activity Bioorg. Chem. 59 2015 23 30
158. S. Botros N.A. Khalil B.H. Naguib Y. El-Dash Synthesis and anticonvulsant activity of new phenytoin derivatives Eur. J. Med. Chem. 60 2013 57 63
159. L. Tripathi P. Kumar R. Singh J.P. Stables Design, synthesis and anticonvulsant evaluation of novel N-(4-substituted phenyl)-2-[4-(substituted) benzylidene]-hydrazinecarbothioamides Eur. J. Med. Chem. 47 2012 153 166
160. M.F. Zayed New fluorinated quinazolinone derivatives as anticonvulsant agents J. Taibah Univ. Med. Sci. 9 2014 104 109
161. K. Wieckowski K. Salat J. Bytnar M. Bajda B. Filipek J.P. Stables B. Malawska Search for anticonvulsant and analgesic active derivative of dihydrofuran-2(3H)-one Bioorg. Med. Chem. 20 2012 6533 6544
162. A. Karakurt M.A. Alagoz B. Sayoglu U. Calis S. Dalkara Synthesis of some novel 1-(2-naphthyl)-2-(imidazol-1-yl)ethanone oxime ester derivatives and evaluation of their anticonvulsant activity Eur. J. Med. Chem. 57 2012 275 282
163. M. Dawidowski J. Chonska W. Mika J. Turlo New fluorinated pyrrolo[1,2-a]pyrazine-2,6-dione derivatives: synthesis and anticonvulsant evaluation in animal models of epilepsy Bioorg. Med. Chem. 22 2014 5410 5427
164. J. Obniska K. Kaminski D. Skrzynska J. Pichor Synthesis and anticonvulsant activity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 3-phenyl-pyrrolidine-2,5-dione Eur. J. Med. Chem. 44 2009 2224 2233
165. J. Obniska H. Byrtus K. Kaminski M. Pawlowski M. Szczesio J.K. Wojciechowska Design, synthesis and anticonvulsant activity of new N-Mannich bases derived from spirosuccinimides and spirohydantoins Bioorg. Med. Chem. 18 2010 6134 6142
166. K. Kaminski J. Obniska B. Wiklik D. Atamanyuk Synthesis and anticonvulsant properties of new acetamide derivatives of phthalimide, and its saturated cyclohexane and norbornene analogs Eur. J. Med. Chem. 46 2011 4634 4641
167. K. Kaminski S. Rzepka J. Obniska Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones Bioorg. Med. Chem. Lett. 21 2011 5800 5803
168. M. Dawidowski F. Herold A. Chodkowski J. Kleps P. Szulczyk M. Wilczek Synthesis and anticonvulsant activity of novel 2,6-diketopiperazine derivatives. Part 1: perhydropyrrole[1,2-a]pyrazines Eur. J. Med. Chem. 46 2011 4859 4869
169. J. Obniska S. Rzepka K. Kaminski Synthesis and anticonvulsant activity of new N-Mannich bases derived from 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones. Part II Bioorg. Med. Chem. 20 2012 4872 4880
170. K. Salat A. Moniczewski R. Salat M. Janaszek B. Filipek B. Malawska K. Weickowski Analgesic, anticonvulsant and antioxidant activities of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one dihydrochloride in mice Pharmacol. Biochem. Behav. 101 2012 138 147
171. K.P. Harish K.N. Mohana L. Mallesha B.N.P. Kumar Synthesis of novel 1-[5-(4-methoxy-phenyl)-[1,3,4]oxadiazol-2-yl]-piperazine derivatives and evaluation of their in vivo anticonvulsant activity Eur. J. Med. Chem. 65 2013 276 283
172. A.M. Waszkielewicz A. Gunia N. Szkaradek K. Pytka A. Siwek G. Satala A.J. Bojarski E. Szneler H. Marona Synthesis and evaluation of pharmacological properties of some new xanthone derivatives with piperazine moiety Bioorg. Med. Chem. Lett. 23 2013 4419 4423
173. K.P. Harish K.N. Mohana L. Mallesha Synthesis of indazole substituted-1,3,4-thiadiazoles and their anticonvulsant activity Drug Invent. Today 5 2013 92 99
174. S. Kumari C.B. Mishra M. Tiwari Design, synthesis and pharmacological evaluation of N- [4-(4-(alkyl/aryl/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents Bioorg. Med. Chem. Lett. 25 2015 1092 1099
175. E. Janberidze M.J. Hjermstad D.F. Haugen K.R. Sigurdardottir E.T. Lohre H.C. Lie J.H. Loge S. Kaasa A.K. Knudsen How are patient populations characterized in studies investigating depression in advanced cancer? Results from a systematic literature J. Pain Symptom Manag. 48 2014 678 698
176. F. Donato M.G. de Gomes A.T.R. Goes N. Seus D. Alves C.R. Jesse L. Savegnago Involvement of the dopaminergic and serotonergic systems in the antidepressant-like effect caused by 4-phenyl-1-(phenylselanylmethyl)-1,2,3-triazole Life Sci. 93 2013 393 400
177. 1A receptor and serotonin transporter: a search for new dual-acting agents as potential antidepressants Eur. J. Med. Chem. 53 2012 124 132
178. K.V. Sashidhara K.B. Rao S. Singh R.K. Modukuri G.A. Teja H. Chandasana S. Shukla R.S. Bhatta Synthesis and evaluation of 3-phenylcoumarin derivatives as potential antidepressant agents Bioorg. Med. Chem. Lett. 24 2014 4876 4880
179. L. Matzen C.V. Amsterdam W. Rautenberg H.E. Greiner J. Harting C.A. Seyfried H. Bottcher 5-HT reuptake inhibitors with 5-HT1B/1D antagonistic activity: a new approach toward efficient antidepressants J. Med. Chem. 43 2000 1149 1157
180. Y. Oshiro Y. Sakurai S. Sato N. Kurahashi T. Tanaka T. Kikuchi K. Tottori Y. Uwahodo T. Miwa T. Nishi 3,4-Dihydro-2-(1H)-quinoline as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-3,4-dihydro-5-methoxy-2(1H)-quinolinone and its derivatives J. Med. Chem. 43 2000 177 189
181. L. Orus S.P. Silanes A.M. Oficialdegui J.M. Esparza J.C.D. Castillo M. Mourelle T. Langer S. Guccione G. Donzella E.M. Krovat K. Poptodorov B. Lasheras S. Ballaz I. Hervias R. Tordera J.D. Rio A. Monge Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT1A receptors J. Med. Chem. 45 2009 4128 4139
182. T. Heinrich H. Bottcher R. Gericke G.D. Bartoszyk S. Anzali C.A. Seyfried H.E. Greiner C.V. Amsterdam Synthesis and structure-activity relationship in a class of indolebutylpiperazines as dual 5-HT1A receptor agonists and serotonin reuptake inhibitors J. Med. Chem. 47 2007 4684 4692
183. 1A receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation J. Med. Chem. 47 2004 2659 2666
184. M.H. Paluchowska R. Bugno B. Duszynska E. Tatarczynska A. Nikiforuk T. Lenda E.C. Wojcik The influence of modifications in imide fragment structure on 5-HT1A and 5-HT7 receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines Bioorg. Med. Chem. 15 2007 7116 7125
185. J.Y. Kim D. Kim S.Y. Kang W.K. Park H.J. Kim M.E. Jung E.J. Son A.N. Pae J. Kim J. Lee Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT2A, 5-HT2C, and the serotonin transporter as a potential antidepressant Bioorg. Med. Chem. Lett. 20 2010 6439 6442
186. 1A/B/D receptor antagonist J. Med. Chem. 53 2010 8228 8240
187. 1A/B/D receptor antagonists leading to the discovery of 6-{2-[4-(2-mehtyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo-[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045) J. Med. Chem. 53 2010 5827 5843
188. B.B. Andersen T. Ruhland M. Jorgensen G. Smith K.F.K.G. Jensen H. Zhong S.M. Nielsen S. Hogg A. Mork T.B. Stensbol Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder J. Med. Chem. 54 2011 3206 3221
189. B.K. Gautam A. Jindal A.K. Dhar R. Mahesh Antidepressant-like activity of 2-(4-phenylpiperazin-1-yl)-1,8-naphthyridine-3-carboxylic acid (7a), a 5-HT3 receptor antagonist in behaviour based rodent models: evidence for the involvement of serotonergic system Pharmacol. Biochem. Behav. 109 2013 91 97
190. P. Karolina R. Anna Z. Malgorzata O. Adrian W. Anna S. Jacek F. Barbara Antidepressant-like activity of a new piperazine derivative of 4 xanthone in the forced swim test in mice: the involvement of 5 serotonergic system Pharmacol. Rep. 67 2014 160 165
191. 1A receptor functional profile Bioorg. Med. Chem. 23 2015 212 221
192. V.C.A. Desai T.M. Cavanaugh C.M.L. Kelton J.J. Guo P.C. Heaton Trends in the utilization of, spending on, and prices for outpatient antifungal agents in US Medicaid programs: 1991-2009 Clin. Ther. 34 2012 2118 2131
193. S. Vandekerckhove H.G. Tran T. Desmet M. D'hooghe Evaluation of (4-aminobutyloxy)quinolines as a novel class of antifungal agents Bioorg. Med. Chem. Lett. 23 2013 4641 4643
194. J.N. Sangshetti F.A.K. Khan R.S. Chouthe M.G. Damale D.B. Shinde Synthesis, docking and ADMET prediction of novel 5-((5-substituted-1-H-1,2,3,4-triazol-3-yl) methyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine as antifungal agents Chin. Chem. Lett. 25 2014 1033 1038
195. M.K. Kathiravan A.B. Salake A.S. Chothe P.B. Dudhe R.P. Watode M.S. Mukta S. Gadhwe The biology and chemistry of antifungal agents: a review Bioorg. Med. Chem. 20 2012 5678 5698
196. L. Li H. Ding B. Wang S. Yu Y. Zou X. Chai Q. Wu Synthesis and evaluation of novel azoles as potent antifungal agents Bioorg. Med. Chem. Lett. 24 2014 192 194
197. R.S. Upadhayaya S. Jain N. Sinha N. Kishore R. Chandra S.K. Arora Synthesis of novel substituted tetrazoles having antifungal activity Eur. J. Med. Chem. 39 2004 579 592
198. Q.Q. He C.M. Liu K. Li Y.B. Cao Design, synthesis of novel antifungal triazole derivatives with high activities against Aspergillus fumigates Chin. Chem. Lett. 18 2007 421 423
199. Q.Y. Sun W.N. Zhang J.M. Xu Y.B. Cao Q.Y. Wu D.Z. Zhang C.M. Liu S.C. Yu Y.Y. Jiang Synthesis and evaluation of novel 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[(4-substituedphenyl)-piperazin-1-yl]-propan-2-ols as antifungal agents Eur. J. Med. Chem. 42 2007 1151 1157
200. X. Che C. Sheng W. Wang Y. Cao Y. Xu H. Ji G. Dong Z. Miao J. Yao W. Zhang New azoles with potent antifungal activity: design, synthesis and molecular docking Eur. J. Med. Chem. 44 2009 4218 4226
201. Z. Yu G. Shi Q. Sun H. Jin Y. Teng K. Tao G. Zhou W. Liu F. Wen T. Hou Design, synthesis and in vitro antibacterial/antifungal evaluation of novel 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7(1-piperazinyl)quinoline-3-carboxylic acid derivatives Eur. J. Med. Chem. 44 2009 4726 4733
202. S. Srinivasan R.M.B. Shafreen P. Nithyanand P. Manisankar S.K. Pandian Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivatives Eur. J. Med. Chem. 45 2010 6101 6105
203. M.S. Arayne N. Sultana U. Haroon M.H. Zuberi S.B.S. Rizvi Synthesis, characterization and biological activity of a series of carboxamide derivatives of ofloxacin Arch. Pharm. Res. 33 2010 1901 1909
204. J. Xu Y. Cao J. Zhang S. Yu Y. Zou X. Chai Q. Wu D. Zhang Y. Jiang Q. Sun Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives Eur. J. Med. Chem. 46 2011 3142 3148
205. X. Chai J. Zhang Y. Cao Y. Zou Q. Wu D. Zhang Y. Jiang Q. Sun New azoles with antifungal activity: design, synthesis, and molecular docking Bioorg. Med. Chem. Lett. 21 2011 686 689
206. M. Rani P. Parthiban R. Ramachandran S. Kabilan Design and synthesis of novel piperazine unit condensed 2,6-diarylpiperidin-4-one derivatives as antituberculosis and antimicrobial agents Med. Chem. Res. 21 2012 653 662
207. U. Kulandaivelu B. Shireesha C. Mahesh J.V. Vidyasagar T.R. Rao K.N. Jayaveera P. Saiko G. Graser T. Szekeres V. Jayaprakash Synthesis antimicrobial and anticancer activity of N′-arylmethylidene-piperazine-1-carbothiohydrazide Med. Chem. Res. 22 2013 2802 2808
208. D. Mandala A. Valeru J. Pochampalli S.R. Vankadari P. Tigulla R. Gatla R. Thampu Synthesis, antimicrobial activity, and molecular modeling of novel 4-(3-(4-benzylpiperazin-1-yl)propoxy)-7-methoxy-3-substituted phenyl-2H-chromen-2-one Med. Chem. Res. 22 2013 5481 5489
209. Z. Jiang Y. Wang W. Wang S. Wang B. Xu G. Fan G. Dong Y. Liu J. Yao Z. Miao W. Zhang C. Sheng Discovery of highly potent triazole antifungal derivatives by heterocycle-benzene bioisosteric replacement Eur. J. Med. Chem. 64 2013 16 22
210. B.Y. Zheng H.P. Zhang M.R. Ke J.D. Huang Synthesis and antifungal photodynamic activities of a series of novel zinc(II) phthalocyanines substituted with piperazinyl moieties Dyes Pigment 99 2013 185 191
211. N.P. Aditya P.G. Vathsala V. Vieira R.S.R. Murthy E.B. Souto Advances in nanomedicines for malaria treatment Adv. Colloid Interfac. Sci. 201-202 2013 1 17
212. S. Mandal Epidemiological aspects of vivax and falciparum malaria: global spectrum Asian Pac. J. Trop. Dis. 4 2014 S13 S26
213. J. Pfeil K.J. Sepp K. Heiss M. Meister A.K. Mueller S. Borrmann Protection against malaria by immunization with non-attenuated sporozoites under single-dose piperaquine-tetraphosphate chemoprophylaxis Vaccine 32 2014 6005 6011
214. M.L.H. Mabaso N.C. Ndlovu Critical review of research literature on climate-driven malaria epidemics in sub-Saharan Africa Public Health 126 2012 909 919
215. D. Leroy B. Campo X.C. Ding J.N. Burrows S. Cherbuin Defining the biology component of the drug discovery strategy for malaria eradication Trends Parasitol. 30 2014 478 490
216. A. Kumar D. Paliwal D. Saini A. Thakur S. Aggarwal D. Kaushik A comprehensive review on synthetic approach for antimalarial agents Eur. J. Med. Chem. 85 2014 147 178
217. R.A. Ghani M.T. Al-Maktari L.A. Al-Shibani A.F. Allam A better resolution for integrating methods for monitoring Plasmodium falciparum resistance to antimalarial drugs Acta Trop. 137 2014 44 57
218. N.F. Walker B. Nadjm C.J.M. Whitty Malar. Med. 42 2014 100 106
219. 1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)-piperazine derivatives Bioorg. Med. Chem. Lett. 15 2005 297 302
220. S. Gemma G. Kukreja G. Campiani S. Butini M. Berntti B.P. Joshi L. Savini N. Basilico D. Taramelli V. Yardley A. Bertamino E. Novellino M. Persico B. Catalanotti C. Fattorusso Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling Bioorg. Med. Chem. Lett. 17 2007 3535 3539
221. G. Auffret M. Labaied F. Frappier P. Rasoanaivo P. Grellier G. Lewin Synthesis and antimalarial evaluation of a series of piperzinyl flavones Bioorg. Med. Chem. Lett. 17 2007 959 963
222. A. Kumar K. Srivastava S.R. Kumar S.K. Puri P.M.S. Chauhan Synthesis and bioevaluation of hybrid 4-aminoquinoline triazines as new class of antimalarial agents Bioorg. Med. Chem. Lett. 18 2008 6530 6533
223. S.C.B. Gnoatto S. Susplugas L.D. Vechia T.B. Ferreira A.D. Klimpt K.R. Zimmer C. Demailly S.D. Nascimento J. Guillon P. Grellier H. Verli G. Gosmann P. Sonnet Pharmacomodulation on the 3-acetylursolic acid skeleton: design, synthesis, and biological evaluation of novel N-{3-[4-(3-aminopropyl)piperazinyl]propyl}-3-O-acetylursolamide derivatives as antimalarial agents Bioorg. Med. Chem. 16 2008 771 782
224. W. Cunico C.R.B. Gomes M. Moreth D.P. Manhanini I.H. Figueiredo C. Penido M.G.M.O. Henriques F.P. Varotti A.U. Krettli Synthesis and antimalarial activity of hydroxyethylpiperazine Eur. J. Med. Chem. 44 2009 1363 1368
225. W. Cunico C.R.B. Gomes V. Facchinetti M. Moreth C. Penido M.G.M.O. Henriques F.P. Varotti L.G. Krettli A.U. Krettli F.S. da Silva E.R. Caffarena C.S. de Magalhaes Synthesis, antimalarial evaluation and molecular modeling studies of hydroxyethylpiperazines, potential aspartyl protease inhibitors, part 2 Eur. J. Med. Chem. 44 2009 3816 3820
226. A. Mendoza S.P. Silanes M. Quiliano A. Pabon S. Galiano G. Gonzalez G. Garavito M. Zimic A. Vaisberg I. Aldana A. Monge E. Deharo Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships Exp. Parasitol. 128 2011 97 103
227. S.I. Pretorius W.J. Breytenbach C. de Kock P.J. Smith D.D. N'Da Synthesis, characterization and antimalarial activity of quinoline-pyrimidine hybrids Bioorg. Med. Chem. 21 2013 269 277
228. M. Sinha V.R. Dola P. Agarwal K. Srivastava W. Haq S.K. Puri S.B. Katti Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain Bioorg. Med. Chem. 22 2014 3573 3586
229. A. Inam S.M. Siddqui T.S. Macedo D.R.M. Moreira A.C.L. Leite M.B.P. Soares A. Azam Design, synthesis and biological evaluation of 3-[4-(7-chloro-quinolin-4-yl)-piperazin-1-yl]-propionic acid hydrazones as antiprotozoal agents Eur. J. Med. Chem. 75 2014 67 76
230. M. Alvarado J. Decara M.J. Luque L.H. Folgado M.G. Canas M.G. Ruiz J.F. Ruiz J. Elguero N. Jagerovic A. Serrano P. Goya F.R. de Fonseca Novel antiobesity agents: synthesis and pharmacological evaluation of analogues of rimonabant and of LH21 Bioorg. Med. Chem. 21 2013 1708 1716
231. 3 receptor antagonist Eur. J. Pharmacol. 487 2004 183 197
232. 6 receptor as a target for developing novel antiobesity drugs Int. Rev. Neurobiol. 96 2011 73 109
233. H. Ziauddeen P.C. Fletcher Central nervous system biomarkers for antiobesity drug development Drug Discov. Today 18 2013 1282 1291
234. K.S. Song S.H. Lee H.J. Chun J.Y. Kim M.E. Jung K. Ahn S.U. Kim J. Kim J. Lee Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands Bioorg. Med. Chem. 16 2008 4035 4051
235. R. Berger C. Zhu A.R. Hansen B. Harper Z. Chen T.G. Holt J. Hubert S.J. Lee J. Pan S. Qian M.L. Reitman A.M. Strack D.T. Weingarth M. Wolff D.J. MacNeil A.E. Weber S.D. Edmondson 2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity Bioorg. Med. Chem. Lett. 18 2008 4833 4837
236. Q. Hong R.K. Bakshi B.L. Palucki M.K. Park Z. Ye S. He P.G. Pollard I.K. Sebhat J. Liu L. Guo D.E. Cashen W.J. Martin D.H. Weinberg T. MacNeil R. Tang C. Tamvakopoulos Q. Peng R.R. Miller R.A. Stearns H.Y. Chen A.S. Chen A.M. Strack T.M. Fong D.E. MacIntyre M.J. Wyvratt R.P. Nargund Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist Bioorg. Med. Chem. Lett. 21 2011 2330 2334
237. M. Simard Y. Turgeon Psychosis and Language second ed. 2006 Enc. Lang. Linguist 275 278
238. P. Stephens K. Chikh H. Leufkens Prescribing of antipsychotics in people with dementia in acute general hospitals in England: 2010-2012 Eur. Geriatr. Med. 5 2014 394 398
239. L.L. Lipscombe P.C. Austin S. Alessi-Severini D.F. Blackburn L. Blais L. Bresee K.B. Filion Y. Kawasumi P. Kurdyak R.W. Platt H. Tamim M. Paterson Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data Schizophr. Res. 154 2014 54 60
240. 4 antagonists as potential antipsychotic agents J. Med. Chem. 43 2000 3923 3932
241. 1A-receptor affinities Bioorg. Med. Chem. Lett. 11 2001 2345 2349
242. 3 receptor subtype J. Med. Chem. 44 2001 3175 3186
243. 2A receptors Eur. J. Med. Chem. 37 2002 503 510
244. M. Tomic M. Kundakovic B. Butorovic B. Janac D. Andric G. Roglic D. Ignjatovic S.K. Rajacic Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential Bioorg. Med. Chem. Lett. 14 2004 4263 4266
245. 1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia Pharmacol. Biochem. Behav. 82 2005 361 372
246. 2 receptor antagonism with potent serotonin reuptake inhibition J. Med. Chem. 48 2005 6855 6869
247. 7 receptor antagonists Bioorg. Med. Chem. 16 2008 5405 5412
248. K.V.G.C. Sekhar V.S. Rao D.R.K. Vyas M.M.K. Kumar Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl)piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents Bioorg. Med. Chem. Lett. 18 2008 6054 6057
249. A. Bali S. Malhotra H. Dhir A. Kumar A. Sharma Synthesis and evaluation of 1-(quinoliloxypropyl)-4-aryl piperazines for atypical antipsychotic effect Bioorg. Med. Chem. Lett. 19 2009 3041 3044
250. A. Bali K. Sharma A. Bhalla S. Bala D. Reddy A. Singh A. Kumar Synthesis, evaluation and computational studies on a series of acetophenone based 1-(aryloxypropyl)-4-(chloroaryl) piperazines as potential atypical antipsychotics Eur. J. Med. Chem. 45 2010 2656 2662
251. C.M. Park S.Y. Kim W.K. Park J.H. Choi C.M. Seong Synthesis and SAR of (piperazin-1-yl-phenyl)-arylsulfonamides: a novel series of atypical antipsychotic agents Bioorg. Med. Chem. Lett. 20 2010 5221 5224
252. S. Kumar A.K. Wahi R. Singh Synthesis, computational studies and preliminary pharmacological evaluation of 2-[4-(aryl substituted) piperazin-1-yl] N,N-diphenylacetamides as potential antipsychotics Eur. J. Med. Chem. 46 2011 4753 4759
253. 3 dopamine receptor ligands J. Med. Chem. 54 2011 1555 1564
254. 2 receptors Bioorg. Med. Chem. Lett. 22 2012 3437 3440
255. S. Kumar A.K. Wahi R. Singh Synthesis, computational studies and preliminary pharmacological evaluation of 2-[4-(aryl substituted) piperazin-1-yl]-N-benzylacetamides as potential antipsychotics Arab. J. Chem. 2012
256. F.M. McRobb I.T. Crosby E. Yuriev J.R. Lane B. Capuano Homobivalent ligands of the atypical antipsychotic clozapine: design, synthesis and pharmacological evaluation J. Med. Chem. 55 2012 1622 1634
257. M.S. Jain S.J. Surana Synthesis and evaluation of antipsychotic activity of 11-(4′-aryl carboxamido/N-aryl-α-phenyl-acetamido)-piperazinyl)-dibenz[b,f][1,4]-oxazepine derivatives Arab. J. Chem. 2013
258. 3 receptors Eur. J. Med. Chem. 60 2013 42 50
259. T.E.T. Pompeu F.R.S. Alves C.D.M. Figueiredo C.B. Antonio V. Herzfeldt B.C. Moura S.M.K. Rates E.J. Barreiro C.A.M. Fraga F. Noel Synthesis and pharmacological evaluation of new N-phenylpiperazine derivatives designed as homologues of the antipsychotic lead compound LASSBio-579 Eur. J. Med. Chem. 66 2013 122 134
260. S.H. Bhosale A.M. Kanhed R.C. Dash M.R. Suryawanshi K.R. Mahadik Design, synthesis, pharmacological evaluation and computational studies of 1-(biphenyl-4-yl)-2-[4-(substituted phenyl)-piperazin-1-yl] ethanones as potential antipsychotics Eur. J. Med. Chem. 74 2014 358 365
261. M.D. Kakwani P. Suryavanshi M. Ray M.G.R. Rajan S. Majee A. Samad P. Devarajan M.S. Degani Design, synthesis and antimycobacterial activity of cinnamide derivatives: a molecular hybridization approach Bioorg. Med. Chem. Lett. 21 2011 1997 1999
262. A.B. Patel K.H. Chikhalia P. Kumari Facile synthesis of benzonitrile/nicotinonitrile based s-triazines as new potential antimycobacterial agents Eur. J. Med. Chem. 79 2014 57 65
263. R.S. Upadhayaya J.K. Vandavasi R.A. Kardile S.V. Lahore S.S. Dixit H.S. Deokar P.D. Shinde M.P. Sarmah J. Chattopadhayaya Novel quinoline and naphthalene derivatives as potent antimycobacterial agents Eur. J. Med. Chem. 45 2010 1854 1867
264. A. Kamal A.H. Babu A.V. Ramana R. Sinha J.S. Yadav S.K. Arora Antitubercular agents. Part 1: synthesis of phthalimido- and naphthalimido-linked phenazines as new prototype antitubercular agents Bioorg. Med. Chem. Lett. 15 2005 1923 1926
265. D. Sriram P. Yogeeswari J.S. Basha D.R. Radha V. Nagarja Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives Bioorg. Med. Chem. 13 2005 5774 5778
266. D. Sriram A. Aubry P. Yogeeswari L.M. Fisher Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase Bioorg. Med. Chem. Lett. 16 2006 2982 2985
267. D. Sriram P. Yogeeswari S.P. Reddy Synthesis of pyrazinamide Mannich bases and its antitubercular properties Bioorg. Med. Chem. Lett. 16 2006 2113 2116
268. D. Sriram P. Yogeeswri G. Senchani D. Banerjee Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial and inhibition of HIV-1 integrase Bioorg. Med. Chem. Lett. 17 2007 2372 2375
269. M. Rani P. Parthiban R. Ramachandran S. Kabilan Design and synthesis of novel piperazine unit condensed 2,6-diarylpiperidin-4-one derivatives as antituberculosis and antimicrobial agents Med. Chem. Res. 21 2012 653 662
270. V. Kanagagarajan M. Gopalakrishnan Pyrimidino piperazinyl acetamides: innovative class of hybrid acetamide drugs as potent antimicrobial and antimycobacterial agents Pharm. Chem. J. 46 2012 26 34
271. H.N. Nagesh K.M. Naidu M. Naidu D.H. Rao J.P. Sridevi D. Sriram P. Yogeeswari K.V.G.C. Sekhar Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents Bioorg. Med. Chem. Lett. 23 2013 6805 6810
272. K.M. Agrawal G.S. Talele Synthesis and antibacterial, antimycobacterial and docking studies of novel N-piperazinyl fluoroquinolones Med. Chem. Res. 22 2013 818 831
273. T.N. Akhaja J.P. Raval New carbodithioate derivatives: synthesis, characterization, and in vitro antibacterial, antifungal, antitubercular, and antimalarial activity Med. Chem. Res. 22 2013 4700 4707
274. H.N. Nagesh A. Suresh S.D.S.S. Sairam D. Sriram P. Yogeeswari K.V.G.C. Sekhar Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues 84 2014 605 613
275. K.N. Patel V.N. Telvekar Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamide derivatives Eur. J. Med. Chem. 75 2014 43 56
276. H.N. Nagesh N. Suresh K.M. Naidu B. Arun J.P. Sridevi D. Sriram P. Yogeeswari K.V.G. Sekhar Synthesis and evaluation of anti-tubercular activity of 6-(4-substituted piperazin-1-yl) phenanthridine analogues Eur. J. Med. Chem. 74 2014 333 339
277. C. Peng C. Gao N. Wang X. You L. Zhang Y. Zhu Y. Xv W. Zuo K. Ran H. Deng Q. Lei K. Xiao L. Xu Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives Bioorg. Med. Chem. Lett. 25 2015 1373 1376
278. M. Marschall I. Niemann K. Kosulin A. Bootz S. Wagner T. Dobner T. Herz B. Kramer J. Leban D. Vitt T. Stamminger C. Hutterer S. Strobl Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis Antivir. Res. 100 2013 640 648
279. J.F. Rossingnol Nitazoxanide: a first-in-class broad spectrum antiviral agent Antivir. Res. 110 2014 94 103
280. J.R. Tagat S.W. McCombie R.W. Steensma S.I. Lin D.V. Nazareno B. Baroudy N. Vantuno S. Xu J. Liu Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element Bioorg. Med. Chem. Lett. 11 2001 2143 2146
281. S.W. McCombie J.R. Tagat S.F. Vice S.I. Lin R. Steensma A. Palani B.R. Neustadt B.M. Baroudy J.M. Strizki M. Endres K. Cox N. Dan C.C. Chou Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: synthesis, antiviral and pharmacokinetic profiles of symmetrical heteroaryl carboxamides Bioorg. Med. Chem. Lett. 13 2003 567 571
282. N. Serradji O. Bensaid M. Martin W. Sallem N.D. Bosquet H. Benmehdi C. Redeuilh A. Lamouri G. Dive P. Clayette F. Heymans Structure-activity relationships in platelet-activating factor. Part 13: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 or pure antiretroviral activity Bioorg. Med. Chem. 14 2006 8109 8125
283. T. Wang J.F. Kadow Z. Zhang Z. Yin Q. Gao D. Wu D.D.G. Parker Z. Yang L. Zadjura B.A. Robinson Y.F. Gong W.S. Blair P.Y. Shi G. Yamanka P.F. Lin N.A. Meanwell Inhibitors of HIV-1 attachment. Part 4: a study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives Bioorg. Med. Chem. Lett. 19 2009 5140 5145
284. H. Wang J. Xiao D. Gao X. Zhang H. Yan Z. Gong T. Sun S. Li Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors Bioorg. Med. Chem. Lett. 21 2011 1057 1059
285. M. Dong L. Lu H. Li X. Wang H. Lu S. Jiang Q. Dai Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperizine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors Bioorg. Med. Chem. Lett. 22 2012 3284 3286
286. D. Dou G. He S.R. Mandadapu S. Aravapalli Y. Kim K.O. Chang W.C. Groutas Inhibition of noroviruses by piperazine derivatives Bioorg. Med. Chem. Lett. 22 2012 377 379
287. L.C.G.A.I. Moreno G.Z.S. Oliveira I.M.F. Cavalcanti N.S. Santos-Magalhaes H.M.L. Rolim R.M. Freitas Development and evaluation of liposomal formulation containing nimodipine on anxiolytic activity in mice Pharmacol. Biochem. Behav. 116 2014 64 68
288. R.L. Prabhu A. Ruckmani D. Venkatesan N. Madhusudhanan R. Pavithra Anxiolytic effect of homeopathic preparation of Pulsatilla nigricans Homeopathy 101 2012 171 174
289. M. Khatri S.K. Rai S. Alam A. Vij M. Tiwari Synthesis and pharmacological evaluation of new arylpiperazines N-{4-[4-(aryl) piperazine-1-yl]-phenyl}-amine derivatives: putative role of 5-HT1A receptors Bioorg. Med. Chem. 17 2009 1890 1897
290. J. Kumar G. Chawla M. Akhtar K. Sahu V. Rathore S. Sahu Design, synthesis and pharmacological evaluation of some novel derivatives of 1-{[3-(furan-2-yl)-5-phenyl-4,5-dihydro-1,2-oxazol-4-yl]methyl}-4-methyl piperazine Arab. J. Chem. 2013
291. X.Y. Luo S.L. Qu Z.H. Tang Y. Zhang M.H. Liu J. Peng H. Tang K.L. Yu C. Zhang Z. Ren Z.S. Jiang SIRT1 in cardiovascular aging Clin. Chim. Acta 437 2014 106 114
292. B.H. Oh R.W.M. Kaligis Y. Wang F.E.R. Punzalan N.C. Suwanwela V.L. Nguyen T.H. Lee K.H. Sim Y. Itoh N. Bahadur J. Leong Survey of atherosclerotic disease in Asian subjects with cardiovascular disease risk factors who were not receiving lipid-lowering agents Int. J. Cardiol. 168 2013 2761 2766
293. Z. Reiner Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update Nutr. Metab. Cardiovasc. Dis. 23 2013 799 807
294. R.M. Kanojia J.J. Salata J. Kauffman Synthesis and class III type antiarrhythmic activity of 4-aroyl (and aryl)-1-aralkylpiperazines Bioorg. Med. Chem. Lett. 10 2000 2819 2823
295. D.D. Holsworth N.A. Powell D.M. Downing C. Cai W.L. Cody J.M. Ryan R. Ostorski M. Jalaie J.W. Bryant J.J. Edmunds Discovery of novel non-peptidic ketopiperazine-based renin inhibitors Bioorg. Med. Chem. 13 2005 2657 2664
296. K. Kulig J. Sapa A. Nowaczyk B. Filipek B. Malawska Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive and α-adrenolytic activity Eur. J. Med. Chem. 44 2009 3994 4003
297. X.C. Cheng X.Y. Liu W.F. Xu X.L. Guo N. Zhang Y.N. Song Ligustrazine derivatives. Part3: design, synthesis and evaluation of novel acylpiperazinyl derivatives as potent cerebrocardiac vascular agents Bioorg. Med. Chem. 17 2009 3018 3024
298. X.K. Liu X. Cui L. Hong L.P. Sun Z.S. Quan H.R. Piao Synthesis of 2-(4-substitutedmethylpiperazin-1-yl)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-7-yl) acetamides and their positive inotropic evaluation Eur. J. Med. Chem. 44 2009 3027 3031
299. K.M. Youssef M.A. Al-Omar H.I. El-Subbagh L.A. Abou-zeid A.G.M.A. Gader N.G. Haress A.S. Al-Tuwaijri Synthesis, antiplatelet aggregation activity, and molecular modeling study of novel substituted-piperazine analogues Med. Chem. Res. 20 2011 898 911
300. L.A.S. Romeiro M.S. Ferreira L.L. da Silva H.C. Castro A.L.P. Miranda C.L.M. Silva F. Noel J.B. Nascimento C.V. Araujo E. Tibirica E.J. Barreiro C.A.M. Fraga Discovery of LASSBIo-772, a 1,3-benzodioxole N-phenylpiperazine derivative with potent alpha 1A/D-adrenergic receptor blocking properties Eur. J. Med. Chem. 46 2011 3000 3012
301. Y. Nakamura C. Sugita M. Meguro S. Miyazaki K. Tamaki M. Takahashi Y. Nagai T. Nagayama M. Kato H. Suemune T. Nishi Design and optimization of novel (2S,4S,5S)-5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxy-2-isopropylhexanamides as renin inhibitors Bioorg. Med. Chem. Lett. 22 2012 4561 4566
302. K.A.M. Abouzid N.A. Khalil E.M. Ahmed 4-Substituted phthalazines and phthazinones: synthesis, characterization and β-adrenergic blocking activity Med. Chem. Res. 22 2013 1057 1064
303. 1-adrenoreceptor affinities Eur. J. Pharmacol. 720 2013 237 246
304. M. Kubacka S. Mogilski B. Filipek H. Marona The hypotensive activity and alpha-1 adrenoreceptor antagonistic properties of some aroxyalkyl derivatives of 2-methoxypheylpiperazine Eur. J. Pharmacol. 698 2013 335 344
305. K.S. Oh B.K. Oh C.H. Park H.W. Seo N.S. Kang J.H. Lee J.S. Lee B.H. Lee Cardiovascular effects of a novel selective Rho kinase inhibitor, 2-(1H-indazole-5-yl)amino-4-methoxy-6-piperazino triazine (DW1865) Eur. J. Pharmacol. 702 2013 218 226
306. A. Borzenko H. Pajouhesh J.L. Morrison E. Tringham T.P. Snutch L.L. Schafer Modular, efficient synthesis of asymmetrically substituted piperazine scaffolds as potent calcium channel blockers Bioorg. Med. Chem. Lett. 23 2013 3257 3261
307. V.L. Gein B.Ya Syropyatov N.N. Kasimova N.V. Dozmorova E.V. Voronina M.I. Vakhrin Synthesis and biological activity of 5-aryl-4-acyl-3-hydroxy-1-(2-piperazin-1-ylethyl)-2,5-dihydropropyl-2-ones and their derivatives Pharm. Chem. J. 47 2013 485 489
308. 1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone Eur. J. Pharmacol. 735 2014 10 16
309. L.X. Ma B.R. Cui Y. Wu J.C. Liu X. Cui L.P. Liu H.R. Piao Synthesis and positive inotropic evaluation of [1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted piperazine moieties Bioorg. Med. Chem. Lett. 24 2014 1737 1741
310. 1-adrenergic receptor blockers Bioorg. Chem. 54 2014 21 30
311. A. Santhoshi S.N. Kumar P. Sujitha Y. Poornachandra P.S. Sadhu C.G. Kumar V.J. Rao Synthesis of 1-benzhydryl piperazine derivatives and evaluation of their ACE inhibition and antimicrobial activities Med. Chem. Res. 23 2014 3207 3219
312. S. Hu Z. Wang T. Hou X. Ma J. Li T. Liu X. Xie Y. Hu Design, synthesis and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists Bioorg. Med. Chem. 23 2015 1157 1168
313. P. Meena V. Nemaysh M. Khatri A. Manral P.M. Luthra M. Tiwari Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease Bioorg. Med. Chem. 23 2015 1135 1148
314. P. Piplani C.C. Danta Design and synthesis of newer potential 4-(N -acetylamino)phenol derived piperazine derivatives as potential cognition enhancers Bioorg. Chem. 60 2015 64 73